Rigel Pharmaceuticals
Asif M. is the Vice President of Global Regulatory Affairs, Quality, Labeling and Medical Writing at Rigel Pharmaceuticals Inc. Asif previously worked as an Executive Director of Regulatory Affairs at various biotechnology companies. Asif holds a Master of Science in Biotechnology from New York University, a Bachelor of Science in Chemistry from the University of Waterloo, and is currently a Ph.D. candidate in Biomedical Sciences at Rutgers University. Asif is responsible for leading global regulatory strategies and quality efforts in the pharmaceutical industry, particularly focusing on immune and hematological disorders, cancers, and rare diseases.
Rigel Pharmaceuticals
3 followers
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.